Case Study:
Helping A Leader in Respiratory Medicine to Improve Referral Pathways in the United Kingdom
The Client
Our client is a world-leader in the development and supply of respiratory medicines, with a strong heritage of providing life-changing therapies to patients who need them.
Their leadership is underlined by their development of an advanced treatment for the treatment of severe respiratory condition and their efforts to improve and accelerate access to patients who need it.
Background
This severe respiratory condition affects ~200,000 people in the UK. Patients diagnosed carry a significantly increased risk of mortality due to their condition.
Often described as ‘difficult to treat’, patients with this condition are diagnosed due to their reliance on rescue therapy despite adherence to routine prescribed treatments, although there is a lack of clarity on a common understanding of a precise disease definition.
Management of this condition in the UK has more recently been transformed by the introduction of advanced treatments which are initiated by specialists in a small number of tertiary care centres.
Opportunity
1,400 people per year die from this respiratory condition in the UK. This makes it critical for patients to be identified, diagnosed and appropriately treated as rapidly as possible. Several barriers to this exist, at present.
The majority of patients are routinely consulting and managed within the primary care setting, usually in general practice. Our client identified the opportunity to address delays to receive optimal treatment that occur with:
Diagnosis not being made due to unclear/misunderstood criteria
Patients ‘lost’ in a loop of referral and discharge between primary & secondary care (not yet reaching tertiary centres)
Time to initiate treatment at tertiary centres may not always be as short as patients may expect
Approach
Triducive began working on this project during 2020-2021 and together with the client team, designed a modified Delphi approach which aimed to create: